The concept, developed together with the University of Turku scientists, is based on the previously unexploited drug target HSD17B1. The endometriotic tissue of women with endometriosis shows high ...

Université Laval has identified PBRM derivatives acting as estradiol 17β-dehydrogenase 1 (HSD17B1; 17β-HSD1) inhibitors reported to be useful for the treatment of cancer.